EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe

Sarah Hersey, Haydar Celik, Steven Rosen, Christopher Scott, Peter Keeling, Laura Joglekar, Mark Lawler

European Journal of Cancer · 2026

DOI: 10.1016/j.ejca.2026.117009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026. Verfasst von Sarah Hersey und 6 weiteren Autor:innen. Beteiligte Einrichtung: Johnston Cancer Research Centre, Queen's University Belfast, School of Medicine, Dentistry & Biomedical Sciences, Belfast, Ireland, UK; Bristol Myers…. Hauptthemen laut MEDLINE: Precision Medicine, Clinical Trials as Topic, Biomarkers, Tumor, Neoplasms. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Higher Education Authority, Health Data Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precision MedicineClinical Trials as TopicBiomarkers, TumorNeoplasmsMedical OncologyDiagnostic Test ApprovalHumansEuropeTime FactorsEuropean Union

Stichwörter der Autor:innen

Clinical trial activationCompanion diagnosticsDrug-diagnostic co-developmentIVDROncologyPersonalized medicinePrecision medicineRegulatory science

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Johnston Cancer Research Centre, Queen's University Belfast, School of Medicine, Dentistry & Biomedical Sciences, Belfast, Ireland, UK; Bristol Myers Squibb, Lawrenceville, NJ, USA. Electronic address: Sarah.hersey@bms.…
  • Bristol Myers Squibb, Lawrenceville, NJ, USA.
  • Wyss Institute, Harvard, Boston, MA, USA.
  • Johnston Cancer Research Centre, Queen's University Belfast, School of Medicine, Dentistry & Biomedical Sciences, Belfast, Ireland, UK; Future Medicines Institute, Queen's University Belfast, Belfast, Ireland, UK.
  • Diaceutics PLC, Belfast, Ireland, UK.
  • Johnston Cancer Research Centre, Queen's University Belfast, School of Medicine, Dentistry & Biomedical Sciences, Belfast, Ireland, UK.

Förderung

  • Higher Education Authority
  • Health Data Research UK

Zitieren

APA

Hersey, S., Celik, H., Rosen, S., Scott, C., Keeling, P., Joglekar, L., & Lawler, M. (2026). Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.117009

Vancouver

Hersey S, Celik H, Rosen S, Scott C, Keeling P, Joglekar L, et al. Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe. European Journal of Cancer. 2026. doi:10.1016/j.ejca.2026.117009

BibTeX
@article{Hersey2026,
  author = {Hersey, Sarah and Celik, Haydar and Rosen, Steven and Scott, Christopher and Keeling, Peter and Joglekar, Laura and Lawler, Mark},
  title = {Diagnostic regulatory pathways are an underrecognized bottleneck in precision oncology clinical trials: Real-world evidence across Europe},
  journal = {European Journal of Cancer},
  year = {2026},
  doi = {10.1016/j.ejca.2026.117009}
}
Kostenlos starten →